{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:27:22Z","timestamp":1769603242796,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:00:00Z","timestamp":1404950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1245\/s10434-014-3854-8","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T18:55:42Z","timestamp":1404932142000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Deep Lymph Node Metastases in the Groin Significantly Affects Prognosis, Particularly in Sentinel Node-Positive Melanoma Patients"],"prefix":"10.1245","volume":"22","author":[{"given":"M. G.","family":"Niebling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. P.","family":"Wevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J. H.","family":"Suurmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"van Ginkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,10]]},"reference":[{"issue":"8","key":"3854_CR1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1470-2045(05)70283-7","volume":"6","author":"AB Francken","year":"2005","unstructured":"Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol. 2005;6(8):608\u2013621.","journal-title":"Lancet Oncol."},{"issue":"36","key":"3854_CR2","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199\u20136206.","journal-title":"J Clin Oncol."},{"issue":"23","key":"3854_CR3","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","volume":"30","author":"SL Wong","year":"2012","unstructured":"Wong SL, Balch CM, Hurley P, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012;30(23):2912\u20132918.","journal-title":"J Clin Oncol."},{"issue":"4","key":"3854_CR4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.sla.0000086543.45557.cb","volume":"238","author":"DL Morton","year":"2003","unstructured":"Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238(4):538\u201349; discussion 549\u201350.","journal-title":"Ann Surg"},{"key":"3854_CR5","unstructured":"John Wayne Cancer Institute. Multicenter Selective Lymphadenectomy Trial II (MSLT-II) [ClinicalTrials.gov identifier NCT00297895]. US National Institutes of Health, ClinicalTrials.gov. Available from: http:\/\/clinicaltrials.gov\/show\/NCT00297895 ."},{"issue":"6","key":"3854_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1470-2045(12)70138-9","volume":"13","author":"BH Burmeister","year":"2012","unstructured":"Burmeister BH, Henderson MA, Ainslie J, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13(6):589\u2013597.","journal-title":"Lancet Oncol."},{"issue":"1","key":"3854_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2004.09.005","volume":"31","author":"E Bastiaannet","year":"2005","unstructured":"Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev. 2005;31(1):18\u201326.","journal-title":"Cancer Treat Rev."},{"issue":"8","key":"3854_CR8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/bjs.1800820819","volume":"82","author":"GD Sterne","year":"1995","unstructured":"Sterne GD, Murray DS, Grimley RP. Ilioinguinal block dissection for malignant melanoma. Br J Surg. 1995;82(8):1057\u20131059.","journal-title":"Br J Surg."},{"issue":"2","key":"3854_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000658-198308000-00009","volume":"198","author":"CM Balch","year":"1983","unstructured":"Balch CM, Durant JR, Bartolucci AA. The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg. 1983;198(2):164\u2013167.","journal-title":"Ann Surg."},{"issue":"7","key":"3854_CR10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1046\/j.1365-2168.2000.01439.x","volume":"87","author":"TM Hughes","year":"2000","unstructured":"Hughes TM, A\u2019Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87(7):892\u2013901.","journal-title":"Br J Surg."},{"issue":"10","key":"3854_CR11","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1245\/s10434-010-1026-z","volume":"17","author":"SB Chang","year":"2010","unstructured":"Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17(10):2764\u20132772.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"3854_CR12","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0","volume":"17","author":"MB Faries","year":"2010","unstructured":"Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010;17(12):3324\u20133329.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"3854_CR13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2008.10.012","volume":"35","author":"HP Poos","year":"2009","unstructured":"Poos HP, Kruijff S, Bastiaannet E, van Ginkel RJ, Hoekstra HJ. Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol. 2009;35(8):877\u2013883.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"3854_CR14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SLA.0b013e31817ed7c3","volume":"248","author":"AJ Spillane","year":"2008","unstructured":"Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg. 2008;248(2):286\u2013293.","journal-title":"Ann Surg."},{"issue":"12","key":"3854_CR15","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1245\/s10434-011-1741-0","volume":"18","author":"AP Ploeg van der","year":"2011","unstructured":"van der Ploeg AP, van Akkooi AC, Schmitz PI, et al. Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection. Ann Surg Oncol. 2011;18(12):3300\u20133308.","journal-title":"Ann Surg Oncol."},{"key":"3854_CR16","doi-asserted-by":"crossref","unstructured":"Hoekstra H, Wobbes T. Radical superficial and deep groin dissection. In: Khatri V (ed). Atlas of advanced operative surgery. 1st ed. Elsevier; 2012:474\u2013481.","DOI":"10.1016\/B978-1-4160-4109-2.00061-1"},{"issue":"10","key":"3854_CR17","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1245\/s10434-007-9512-7","volume":"14","author":"B Badgwell","year":"2007","unstructured":"Badgwell B, Xing Y, Gershenwald JE, et al. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol. 2007;14(10):2867\u20132875.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"3854_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/028418601750071091","volume":"40","author":"L Kretschmer","year":"2001","unstructured":"Kretschmer L, Neumann C, Preusser KP, Marsch WC. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin: an analysis of survival and local recurrence. Acta Oncol. 2001;40(1):72\u201378.","journal-title":"Acta Oncol."},{"issue":"4","key":"3854_CR19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/ejso.2001.1262","volume":"28","author":"T Meyer","year":"2002","unstructured":"Meyer T, Merkel S, Gohl J, Hohenberger W. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol. 2002;28(4):424\u2013430.","journal-title":"Eur J Surg Oncol."},{"issue":"11","key":"3854_CR20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1445-2197.2008.04716.x","volume":"78","author":"CP Allan","year":"2008","unstructured":"Allan CP, Hayes AJ, Thomas JM. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. ANZ J Surg. 2008;78(11):982\u2013986.","journal-title":"ANZ J Surg."},{"issue":"8","key":"3854_CR21","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1245\/s10434-008-9965-3","volume":"15","author":"ZI Nowecki","year":"2008","unstructured":"Nowecki ZI, Rutkowski P, Michej W. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion breslow thickness greater than 1.0 and less than or equal to 4\u00a0mm (pT2-pT3). Ann Surg Oncol. 2008;15(8):2223\u20132234.","journal-title":"Ann Surg Oncol."},{"key":"3854_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7819-11-36","volume":"11","author":"N Mozzillo","year":"2013","unstructured":"Mozzillo N, Caraco C, Marone U, et al. Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors. World J Surg Oncol. 2013;11:36.","journal-title":"World J Surg Oncol."},{"issue":"3","key":"3854_CR23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejso.2012.12.014","volume":"39","author":"M Zdzienicki","year":"2013","unstructured":"Zdzienicki M, Rutkowski P, Nowecki ZI, et al. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases. Eur J Surg Oncol. 2013;39(3):304\u2013310.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"3854_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CMR.0b013e328329fe7d","volume":"19","author":"M Santinami","year":"2009","unstructured":"Santinami M, Carbone A, Crippa F, et al. Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes. Melanoma Res. 2009;19(2):112\u2013118.","journal-title":"Melanoma Res."},{"issue":"12","key":"3854_CR25","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1245\/s10434-011-1750-z","volume":"18","author":"CK Chu","year":"2011","unstructured":"Chu CK, Delman KA, Carlson GW, Hestley AC, Murray DR. Inguinopelvic lymphadenectomy following positive inguinal sentinel lymph node biopsy in melanoma: true frequency of synchronous pelvic metastases. Ann Surg Oncol. 2011;18(12):3309\u20133315.","journal-title":"Ann Surg Oncol."},{"key":"3854_CR26","unstructured":"Pasquali S, Vecchiato A, Bigolin F, Montesco MC, Di Maggio A, Mocellin S, et al. Iliac lymph nodes metastasis after ilio-inguinal radical lymph node dissection for melanoma. Presented at the Society of Surgical Oncology 66th Annual Cancer Symposium; 2013 Mar 6\u20139; National Harbor (MD)."},{"issue":"2","key":"3854_CR27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archsurg.1989.01410020032004","volume":"124","author":"DG Coit","year":"1989","unstructured":"Coit DG, Brennan MF. Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg. 1989;124(2):162\u2013166.","journal-title":"Arch Surg."},{"issue":"3","key":"3854_CR28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10434-999-0263-5","volume":"6","author":"GB Mann","year":"1999","unstructured":"Mann GB, Coit DG. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol. 1999;6(3):263\u2013271.","journal-title":"Ann Surg Oncol."},{"issue":"28","key":"3854_CR29","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1200\/JCO.2008.20.1822","volume":"27","author":"E Bastiaannet","year":"2009","unstructured":"Bastiaannet E, Wobbes T, Hoekstra OS, et al. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. J Clin Oncol. 2009;27(28):4774\u20134780.","journal-title":"J Clin Oncol."},{"key":"3854_CR30","doi-asserted-by":"crossref","unstructured":"Ho Shon IA, Chung DK, Saw RP, Thompson JF. Imaging in cutaneous melanoma. Nucl Med Commun. 2008;29(10):847\u2013876.","DOI":"10.1097\/MNM.0b013e32830439fb"},{"issue":"1","key":"3854_CR31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ultrasmedbio.2012.08.024","volume":"39","author":"T Hinz","year":"2013","unstructured":"Hinz T, Voth H, Ahmadzadehfar H, et al. Role of high-resolution ultrasound and PET\/CT imaging for preoperative characterization of sentinel lymph nodes in cutaneous melanoma. Ultrasound Med Biol. 2013;39(1):30\u201336.","journal-title":"Ultrasound Med Biol."},{"issue":"2","key":"3854_CR32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","volume":"103","author":"Y Xing","year":"2011","unstructured":"Xing Y, Bronstein Y, Ross MI, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103(2):129\u2013142.","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"3854_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0959-8049(02)00534-8","volume":"39","author":"L Kretschmer","year":"2003","unstructured":"Kretschmer L, Altenvoerde G, Meller J, et al. Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma. Eur J Cancer. 2003;39(2):175\u2013183.","journal-title":"Eur J Cancer."},{"issue":"5","key":"3854_CR34","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1245\/s10434-008-9840-2","volume":"15","author":"IM Ploeg van der","year":"2008","unstructured":"van der Ploeg IM, Valdes Olmos RA, Kroon BB, Nieweg OE. Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection? Ann Surg Oncol. 2008;15(5):1485\u20131491.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"3854_CR35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/2012.jama.11030","volume":"308","author":"I Stoffels","year":"2012","unstructured":"Stoffels I, Boy C, Poppel T, et al. Association between sentinel lymph node excision with or without preoperative SPECT\/CT and metastatic node detection and disease-free survival in melanoma. JAMA. 2012;308(10):1007\u20131014.","journal-title":"JAMA."},{"issue":"8","key":"3854_CR36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0748-7983(03)00147-1","volume":"29","author":"K Havenga","year":"2003","unstructured":"Havenga K, Cobben DC, Oyen WJ, et al. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol. 2003;29(8):662\u2013664.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"3854_CR37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00259-012-2168-y","volume":"39","author":"L Rbah-Vidal","year":"2012","unstructured":"Rbah-Vidal L, Vidal A, Besse S, et al. Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [(1)(0)F]ICF01006, a highly promising melanoma PET tracer. Eur J Nucl Med Mol Imaging. 2012;39(9):1449\u20131461.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"2","key":"3854_CR38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00000658-198208000-00010","volume":"196","author":"SJ Finck","year":"1982","unstructured":"Finck SJ, Giuliano AE, Mann BD, Morton DL. Results of ilioinguinal dissection for stage II melanoma. Ann Surg. 1982;196(2):180\u2013186.","journal-title":"Ann Surg."},{"issue":"12","key":"3854_CR39","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/bjs.1800811221","volume":"81","author":"CP Karakousis","year":"1994","unstructured":"Karakousis CP, Driscoll DL. Groin dissection in malignant melanoma. Br J Surg. 1994;81(12):1771\u20131774.","journal-title":"Br J Surg."},{"issue":"4","key":"3854_CR40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9610(97)89622-5","volume":"171","author":"CP Karakousis","year":"1996","unstructured":"Karakousis CP, Driscoll DL. Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg. 1996;171(4):421\u2013422.","journal-title":"Am J Surg."},{"issue":"5","key":"3854_CR41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0002-9610(86)90211-4","volume":"152","author":"CP Karakousis","year":"1986","unstructured":"Karakousis CP, Emrich LJ, Rao U. Groin dissection in malignant melanoma. Am J Surg. 1986;152(5):491\u2013495.","journal-title":"Am J Surg."},{"key":"3854_CR42","unstructured":"EORTC 1208 (Minitub). Available from: http:\/\/www.melanomagroup.eu\/site\/databasefor-melanoma-group-member\/minitub.html ."},{"key":"3854_CR43","unstructured":"Australia and New Zealand Melanoma Trials Group. Proposed trial 1. ANZMTG 01.12 inguinal or ilio-inguinal lymphadenectomy for patients with metastatic melanoma to groin lymph nodes and no evidence of pelvic disease on PET\/CT scan: a randomised pahse III trial (EAGLE FM). Available from: http:\/\/anzmtg.org\/trialdetails.aspx?trialno=9 ."},{"issue":"6","key":"3854_CR44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u2013575.","journal-title":"JAMA."},{"key":"3854_CR45","unstructured":"GlaxoSmithKline. A study of the BRAF inhibitor dabrafenib in combination with the MEK inhibitor trametinib in the adjuvant treatment of high-risk BRAF V600 mutation-positive melanoma after surgical resection (COMBI-AD) [ClinicalTrials.gov identifier NCT01682083]. US National Institutes of Health, ClinicalTrials.gov. Available from: http:\/\/clinicaltrials.gov\/show\/NCT01682083 ."},{"issue":"16","key":"3854_CR46","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1200\/JCO.2012.45.3845","volume":"31","author":"K Koers","year":"2013","unstructured":"Koers K, Francken AB, Haanen JB, Woerdeman LA, van der Hage JA. Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma. J Clin Oncol. 2013;31(16):e251\u20133.","journal-title":"J Clin Oncol."},{"issue":"4","key":"3854_CR47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02303564","volume":"1","author":"CP Karakousis","year":"1994","unstructured":"Karakousis CP, Driscoll DL, Rose B, Walsh DL. Groin dissection in malignant melanoma. Ann Surg Oncol. 1994;1(4):271\u2013277.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"3854_CR48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10434-999-0255-5","volume":"6","author":"LJ Strobbe","year":"1999","unstructured":"Strobbe LJ, Jonk A, Hart AA, Nieweg OE, Kroon BB. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol. 1999;6(3):255\u2013262.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3854-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3854-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T03:27:25Z","timestamp":1689391645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3854-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,10]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3854"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3854-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,10]]}}}